A coronavirus vaccine developed by Pfizer and BioNTech uses a Canadian company's nanotechnology. Acuitas Therapeutics' lipid nanoparticles technology helps messenger RNA get to its targets in the body, the company says.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.